Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

BACKGROUND: Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in combination with metformin in patients with type 2...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Med
Main Authors: Pérez-Belmonte, Luis M., Torres-Peña, José David, López-Carmona, María D., Ayala-Gutiérrez, M. Mar., Fuentes-Jiménez, Francisco, Jorge Huerta, Lucía, Muñoz, Jaime Alonso, Rubio-Rivas, Manuel, Madrazo, Manel, Garcia, Marcos Guzmán, Montes, Beatriz Vicente, Sola, Joaquim Fernández, Ena, Javier, Ferrer, Ruth Gonzalez, Pérez, Carmen Mella, Ripper, Carlos Jorge, Lecumberri, Jose Javier Napal, Acedo, Iris El Attar, Canteli, Susana Plaza, Cosío, Sara Fuente, Martínez, Francisco Amorós, Rodríguez, Begoña Cortés, Pérez-Martínez, Pablo, Ramos-Rincón, José Manuel, Gómez-Huelgas, Ricardo
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7666969/
https://ncbi.nlm.nih.gov/pubmed/33190637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-020-01832-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares